All news (page 93)

3 March 2026

RIFT Secures €114M to Scale Iron Fuel Technology

€113.8M funding will develop a commercial iron fuel facility, aiming to decarbonize industrial heat and avoid over 1M tonnes of CO₂ emissions. Operational by 2029.
3 March 2026

TotalEnergies and AllianzGI Partner for 800 MW Battery Storage in Germany

TotalEnergies sells 50% stake in 11 battery projects to AllianzGI, investing €500M in Germany's energy infrastructure, operational by 2028, enhancing grid resilience and renewable support.
3 March 2026

Clariant and Vertimass Partner to Scale CADO Biofuels Technology

The partnership aims to scale zeolite catalysts for converting biobased alcohols into liquid fuels, combining decades of expertise with innovative technology for sustainable fuel production.
2 March 2026

KPS Completes Acquisition of Ketjen Refining Catalyst Business

New ownership will accelerate catalyst and additive R&D, deploy AI/advanced analytics, and retain a global manufacturing and technical support network.
2 March 2026

Carbon Direct and C2X advance Beaver Lake forestry-residue-to-biomethanol project

Transforms Louisiana forestry and sawmill residues into biomethanol and durable CO₂ storage; FEED nearing completion, FID targeted in 2026 with production from 2029.
2 March 2026

Grupa Azoty Strengthens Management Board for Strategic Restructuring

New leadership focuses on financial stability, asset efficiency, and high-growth segments in a major organizational renewal.
2 March 2026

SPIE Acquires ROFA Industrial Automation AG in Germany

SPIE expands its industrial services in Germany, enhancing automation and intralogistics capabilities, with expected growth in EBITA and EPS. Transaction completes in Q2 2026.
2 March 2026

Novo Nordisk Employee Board Elections Completed

Four employee representatives and four substitutes were elected to Novo Nordisk's Board. New members join post-AGM on 26 March 2026. Two current members will resign.
2 March 2026

EIB and Canada Collaborate on Raw Material Resilience

A Letter of Intent was signed to enhance cooperation on critical raw materials, aiming to secure sustainable supply chains for Europe's green and digital transitions.
2 March 2026

Tecnimont Secures $1.3B EPC Contract

Tecnimont will execute a $1.3B EPC contract for a hydrocarbon plant, including utilities and offsite facilities, with completion expected by 2031.
2 March 2026

PPG, IPG Photonics, Whirlpool Advance Laser-Based Powder Curing

Laser curing offers faster, energy-efficient powder coating, reducing costs and environmental impact. Pilot trials underway to enhance productivity and sustainability.
2 March 2026

QatarEnergy Halts LNG Production

Military attacks on facilities in Qatar have led to a halt in LNG production. QatarEnergy is committed to keeping stakeholders informed.
2 March 2026

Novo Nordisk Invests €432M in Athlone Facility Expansion

The investment boosts GLP-1 production, creates 500 construction jobs, and enhances Ireland's role in global supply outside the US. Completion expected by 2028.
2 March 2026

BASF Sells Optical Brightening Agent Business to Catexel

The transaction includes international operations and 80 employees. Catexel, part of ICIG, specializes in specialty chemicals for detergents and cleaning products.
2 March 2026

Takeda's Rusfertide Receives FDA Priority Review

Rusfertide shows promise in controlling hematocrit and reducing symptoms in polycythemia vera, with FDA review based on positive Phase 3 and long-term study data.
2 March 2026

Equinor's Rapid Development Plan for Snorre Oil Discovery

New oil discovery in Snorre area to be quickly developed using existing infrastructure, reducing costs and environmental impact, while supporting European energy security.
2 March 2026

thyssenkrupp Uhde to Study Biomass-to-Methanol Integration for Nova Sustainable Fuels in Canada

The study will assess the integration of gasification and methanol synthesis to produce 450,000 metric tons of bio-methanol annually, aiding decarbonization in transportation and shipping.
2 March 2026

Galp 4Q & FY25 Financial Results

Strong 2025 performance with €2.2bn cash generation, 4% DPS increase, and €250m buyback. Key growth in Brazil, Namibia, and Sines. Net debt at €1.3bn, FCF at €81m.
2 March 2026

WuXi Biologics in S&P Global Sustainability Yearbook for Fourth Year

Recognized for top sustainability performance, achieving a Top 1% S&P Global CSA Score, and earning multiple ESG accolades across various indices and initiatives.
2 March 2026

Mitsui Chemicals Unveils AI for Efficient R&D Literature Reviews

An AI agent reduces literature review time by 80%, automating compound identification and data extraction from scientific texts, enhancing R&D efficiency.
1 March 2026

Dangote Cement signs $1bn deal with Sinoma for 12 African cement projects

Deal backs new plants, expansions and upgrades across Africa to raise capacity toward an 80 MTPA 2030 target, secure gas supply, improve efficiency, cut emissions and create jobs.
1 March 2026

Genentech's Fenebrutinib Shows Promise as BTK Inhibitor for MS in Phase III Study

Fenebrutinib reduced relapses by 51% in RMS, consistent with prior studies. Data will be submitted to regulators. Safety profile comparable to teriflunomide; further analysis on fatalities ongoing.
28 February 2026

Merck's KEYTRUDA and WELIREG Combo Reduces RCC Recurrence Risk by 28%

Phase 3 trial shows KEYTRUDA and WELIREG improve disease-free survival in RCC. FDA accepts priority review for adjuvant treatment. Safety profile consistent with previous studies.
28 February 2026

Merck and Eisai: WELIREG and LENVIMA Reduce Disease Progression Risk by 30% in Advanced RCC Trial

Phase 3 trial shows WELIREG plus LENVIMA improves progression-free survival in advanced RCC, with FDA reviewing new drug applications.
27 February 2026

CATL and BMW MOU on Battery Passport and Decarbonization

MOU to run pilots for cross-border Battery Passport data exchange, carbon accounting and Catena‑X standards, aligning tech, policies and EU compliance to boost low‑carbon competitiveness.
27 February 2026

PETRONAS Reports Lower Profit Amid Market Challenges, Focuses on Long-Term Value

Revenue and profit decreased due to lower prices and sales. PETRONAS prioritizes resilience and strategic growth amid ongoing market volatility and geopolitical challenges.
27 February 2026

ZILS Investments Surpass €20 Billion, Boosting Regional Growth

ZILS attracts major investments in energy, industry, and tech, enhancing Sines' role as a key production and export hub, creating jobs and boosting economic competitiveness.
27 February 2026

FDA Approves Novo Nordisk's Sogroya for New Pediatric Uses

Sogroya, a once-weekly growth hormone, is now approved for children with ISS, SGA, or NS, offering an alternative to daily injections and expanding treatment options.
27 February 2026

Merck's KEYTRUDA and Padcev Cut Event-Free Survival Risk by 47% and Mortality by 35% in Cisplatin-Eligible Bladder Cancer Patients

KEYTRUDA plus Padcev improves survival and reduces recurrence in muscle-invasive bladder cancer, showing potential as a new standard for cisplatin-eligible patients.
27 February 2026

Merck's KEYTRUDA Plus Paclitaxel Boosts Survival in Platinum-Resistant Ovarian Cancer

KEYTRUDA plus paclitaxel improves overall survival in platinum-resistant ovarian cancer, regardless of PD-L1 status, as shown in the KEYNOTE-B96 trial.

← Previous Next →